Oxurion receives a transparency notification from Atlas Special Opportunities II LLC

Leuven, Belgium – Oxurion NV, a company based in Leuven, announced that it has received a transparency notification in accordance with Belgian law. Atlas Special Opportunities II LLC informed Oxurion that, as of January 14, 2026, it held 8,716,030 shares of the company, exceeding the 10% threshold of the 70,098,394 outstanding shares through the purchase of voting securities.

Oxurion specializes in acquiring majority stakes in promising European pharmaceutical contract manufacturers. The company aims to build an integrated group of contract manufacturers serving the healthcare sector.